julio 2020 – Página 69

Unidos Contra El Cáncer® anuncia nueva iniciativa de investigación y educación dedicada a mejorar la igualdad en la salud para los pacientes de pocos recursos que tienen cáncer de pulmón

NUEVA YORK, 16 de julio de 2020 /PRNewswire-HISPANIC PR WIRE/ — Unidos Contra El Cáncer anunció hoy una nueva subvención de $5 millones de Bristol Myers Squibb para financiar las iniciativas de investigación y educación dirigidas a lograr la igualdad en la salud para los pacientes de pocos recursos que tienen cáncer de pulmón, incluidas las personas negras y personas que viven en las comunidades rurales. A pesar del reciente progreso en el tratamiento del cáncer de pulmón, la enfermedad…

Las iniciativas de investigación financiadas por la subvención de tres años constarán de subsidios complementarios para los equipos de investigación actuales de Unidos Contra El Cáncer. Las subvenciones complementarias estarán orientadas a identificar nuevos e innovadores métodos de diagnóstico y tratamiento para los pacientes con cáncer de pulmón que pasan necesidad. Estas subvenciones complementarias serán diseñadas para iniciar proyectos piloto en los que confluyan los cánceres de pulmón, las desigualdades en la salud y la atención médica rural. Por ejemplo, garantizar que el acceso a tratamientos para salvar vidas esté disponible para los grupos que tradicionalmente han tenido poca representación.

A principios de 2021, una Cumbre de Innovación de Unidos Contra El Cáncer lanzará el proyecto, que unirá a los expertos de cáncer de pulmón con los investigadores que se especializan en la igualdad en la salud y el acceso. El proceso competitivo de aplicación y selección de la subvención para los proyectos propuestos serán supervisados por el Comité Asesor Científico de Unidos Contra El Cáncer.

«La cartera de Unidos Contra El Cáncer ya incluye 17 proyectos de equipos de ciencias sobre cáncer de pulmón, y se han financiado 24 ensayos clínicos sobre cáncer de pulmón hasta la fecha», dijo el premio Nobel Phillip A. Sharp, PhD, presidente del Comité Asesor Científico de Unidos Contra El Cáncer, y profesor del Instituto David H. Koch para la Investigación Integrativa del Cáncer del Instituto de Tecnología de Massachusetts. «Con esta red integral de cáncer de pulmón y la dedicación para diversificar los ensayos clínicos sobre el cáncer, Unidos Contra El Cáncer aprovechará la subvención Bristol Myers Squibb para alcanzar a los pacientes con cáncer de pulmón que históricamente han sido marginados por nuestro sistema de atención de la salud».

La pandemia de la COVID-19 ha destacado las arraigadas desigualdades en la atención de la salud que enfrentan las comunidades de color en los EE. UU. Muchas de las mismas condiciones económicas y sociales que contribuyen activamente a las desigualdades en pruebas y tratamiento para la COVID-19 han creado las desigualdades en la atención del cáncer durante décadas. Actualmente, solo el 4 % de los participantes de ensayos clínicos sobre cáncer son de raza negra y 5 % son hispanos, de acuerdo con los datos de la FDA. Unidos Contra El Cáncer y Bristol Myers Squibb están comprometidos con abordar los problemas en las desigualdades de la atención del cáncer. La iniciativa de igualdad en salud de Unidos Contra El Cáncer se dedica a aumentar la participación diversa en los ensayos clínicos sobre el cáncer y Bristol Myers Squibb ha demostrado su compromiso de favorecer la igualdad en la salud a través del apoyo a programas que abordan las desigualdades en la atención de la salud y extienden los avances médicos a las comunidades necesitadas en todo el mundo.

«Estamos muy agradecidos con Bristol Myers Squibb por esta subvención, que une nuestros objetivos comunes de mejorar la atención del cáncer para las comunidades de pocos recursos», dijo Sung Poblete, PhD, RN, directora ejecutiva de Unidos Contra El Cáncer. «Este es el tipo de compromiso y la colaboración necesaria para garantizar que todos los pacientes con cáncer se beneficien equitativamente de los avances en la investigación y el tratamiento».

«A pesar del asombroso progreso reciente en el diagnóstico y el tratamiento del cáncer, las desigualdades en la atención que experimentan las poblaciones de pacientes de pocos recursos son persistentes y agudas», explicó Adam Lenkowsky, gerente general y jefe de Oncología, Inmunología, Cardiovascular, Bristol Myers Squibb en EE. UU. «Como compañía enfocada en transformar la vida de los pacientes a través de la ciencia, nos dedicamos a mejorar los resultados de salud de todos los pacientes. Nuestro apoyo al trabajo de Unidos Contra El Cáncer para hacer frente a la carga del cáncer de pulmón entre las comunidades diversas y rurales es otra extensión de nuestro compromiso permanente para asegurar que cada paciente tenga acceso a atención de calidad».

Desde 2014, Bristol Myers Squibb ha brindado financiación para importantes iniciativas de investigación de Unidos Contra El Cáncer. Bristol Myers Squibb fue el donante inaugural para SU2C Catalyst®, que apoya la investigación y los ensayos clínicos sobre una amplia variedad de tipos de cáncer, incluidos el cáncer de pulmón de células no pequeñas, el melanoma metastásico, el mieloma múltiple indolente, los cánceres pediátricos hipermutantes, los tumores cerebrales pediátricos y el neuroblastoma pediátrico. La financiación también ha apoyado las subvenciones de convergencia, que aprovechan la ciencia computacional para comprender la biología fundamental del cáncer, las subvenciones de investigación innovadora enfocadas en la inmunoncología, así como los Equipos de Ensueño enfocados en el cáncer de pulmón.

La iniciativa de igualdad en salud de Unidos Contra El Cáncer formaliza los requisitos que se aplicarán a todos los equipos futuros que busquen la financiación de Unidos Contra El Cáncer. Los requisitos incluyen abordar el reclutamiento y la retención de pacientes de diferentes grupos étnicos y comunidades de pocos recursos para mejorar la participación diversa en ensayos clínicos sobre el cáncer. Para mejorar la educación de ensayos clínicos sobre el cáncer, el alcance y el reclutamiento en las comunidades de pocos recursos, Unidos Contra El Cáncer colabora con organizaciones comunitarias y de defensa como Black Women’s Health Imperative y Friends of Cancer Research.

Bristol Myers Squibb lleva mucho tiempo comprometida a favorecer la igualdad en la salud y continúa forjando colaboraciones e invirtiendo en programas para aumentar el alcance de la innovación médica a las poblaciones diversas y agobiadas. Un ejemplo importante del compromiso de la compañía en esta área es el trabajo de la Bristol Myers Squibb Foundation, que durante más de 20 años ha puesto en marcha iniciativas en todo el mundo para mejorar los resultados de la salud de aquellas personas afectadas desproporcionadamente por las enfermedades graves. Esto incluye iniciativas que se centran en las poblaciones de pocos recursos en el sudeste de Estados Unidos, donde la carga de cáncer de pulmón es la más alta, con un enfoque personalizado en modelos innovadores de prevención, detección, y educación, mientras que ayuda a las personas con cáncer de pulmón a acceder y recorrer los servicios de atención y apoyo para el cáncer. Desde 2014 a 2019, Bristol Myers Squibb Foundation aportó $35 millones para ampliar el alcance de los recursos comunitarios y los programas de apoyo para sobrevivientes de cáncer para las poblaciones de pocos recursos en los EE. UU.

Acerca de Unidos Contra El Cáncer

Unidos Contra El Cáncer recauda fondos para acelerar el ritmo de la investigación para llevar nuevas terapias a los pacientes rápidamente y salvar vidas ahora. Unidos Contra El Cáncer, una división de Entertainment Industry Foundation, una organización caritativa 501(c)(3), fue establecida en 2008 por líderes del sector de medios y entretenimiento que utilizan los recursos de estas comunidades para involucrar al público en el apoyo a un nuevo modelo colaborativo de investigación del cáncer, aumentar la conciencia sobre la prevención del cáncer y resaltar el progreso que se está logrando en la lucha contra la enfermedad. Al mes de enero de 2020, más de 1,600 científicos que representan a más de 180 instituciones están involucrados en proyectos de investigación financiados por Unidos Contra El Cáncer.

El personal de Unidos Contra El Cáncer trabaja bajo la dirección de nuestro Comité de Asesoría Científica, dirigido por el premio Nobel Phillip A. Sharp, Ph.D., para implementar rigurosos y competitivos procesos de revisión destinados a identificar las mejores propuestas de investigación que serán recomendadas para entrega de financiación, supervisar la administración de las subvenciones y verificar que exista un trabajo colaborativo entre los diferentes programas de investigación.

Los miembros actuales del Consejo de Fundadores y Asesores (Council of Founders and Advisors, CFA) de Unidos Contra El Cáncer incluyen a Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams y Ellen Ziffren. Laura Ziskin y Noreen Fraser, ya fallecidas, son también cofundadoras. La Dra. Sung Poblete, PhD, R.N., se desempeña como directora ejecutiva de Unidos Contra El Cáncer. Para obtener más información, visite StandUpToCancer.org.

Acerca de Bristol Myers Squibb
Bristol Myers Squibb es una compañía biofarmacéutica global cuya misión es descubrir, desarrollar y brindar medicamentos innovadores para ayudar a los pacientes a derrotar enfermedades graves. Para obtener más información acerca de Bristol Myers Squibb, visítenos en BMS.com o síganos en LinkedIn, Twitter, YouTube, Facebook, e Instagram.

Logo – https://mma.prnewswire.com/media/1082531/Unidos_Contra_El_Cancer_Logo.jpg
Logo – https://mma.prnewswire.com/media/1215551/bms_logo_rgb_pos_300_Logo.jpg

FUENTE Unidos Contra El Cáncer

Stand Up To Cancer® announces new research and education effort focused on improving health equity for underserved lung cancer patients

NEW YORK, July 16, 2020 /PRNewswire-HISPANIC PR WIRE/ — Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities. Despite recent progress in treating lung cancer, the disease remains the leading cause of cancer death in the U.S. with particularly high death rates in rural…

The research efforts funded by the three-year grant will consist of supplemental grants to current Stand Up To Cancer research teams. The supplemental grants will focus on identifying new and innovative diagnostic and treatment methods for lung cancer patients in need. These supplemental grants will be designed to jumpstart pilot projects at the intersection of lung cancers, health disparities and rural healthcare, for instance increasing clinical trial enrollment among historically under-represented groups.

In early 2021, a Stand Up To Cancer Innovation Summit will launch the project, bringing together lung cancer experts with researchers specializing in health equity and access. The competitive grant application and selection process for proposed projects will be overseen by Stand Up To Cancer’s Scientific Advisory Committee.

«Stand Up To Cancer’s portfolio already includes 17 team science projects in lung cancer, and 24 lung cancer clinical trials have been funded to date,» said Nobel Laureate Phillip A. Sharp, PhD, chair of the SU2C Scientific Advisory Committee, and Institute professor, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology. «With this comprehensive lung cancer network and the dedication to diversifying cancer clinical trials, Stand Up To Cancer will leverage the Bristol Myers Squibb grant to reach lung cancer patients who have historically been marginalized by our health care system.»

The COVID-19 pandemic has brought to the forefront the longstanding health care disparities faced by communities of color in the U.S. Many of the same economic and social conditions that are actively contributing to COVID-19 testing and treatment inequities have created disparities in cancer care for decades. Currently, only 4% of cancer clinical trial participants are Black and 5% are Hispanic, according to FDA data. Stand Up To Cancer and Bristol Myers Squibb are committed to addressing issues in cancer care inequities. Stand Up to Cancer’s Health Equity Initiative is dedicated to increasing diverse participation in cancer clinical trials and Bristol Myers Squibb has long demonstrated its commitment to fostering health equity through support of programs that address disparities in health care and extend medical advances to communities in need around the world.

«We are so thankful to Bristol Myers Squibb for this grant, which unites our common goals of improving cancer care for underserved communities,» said Sung Poblete, PhD, RN, CEO of Stand Up To Cancer. «This is the type of commitment and collaboration needed to ensure all cancer patients benefit equally from advances in research and treatment.»

«Despite the remarkable recent progress in the diagnosis and treatment of cancer, the disparities in care experienced by underserved patient populations are persistent and acute,» said Adam Lenkowsky, general manager and head, U.S., Oncology, Immunology, Cardiovascular, Bristol Myers Squibb. «As a company focused on transforming patients’ lives through science, we are dedicated to improving health outcomes for all patients. Our support of Stand Up to Cancer’s work to address the burden of lung cancer among diverse and rural communities is another extension of our long-standing commitment to ensuring that every patient has access to quality care.»

Since 2014, Bristol Myers Squibb has provided funding for important Stand Up To Cancer research initiatives. Bristol Myers Squibb was the inaugural donor for SU2C Catalyst®, supporting research and clinical trials targeting a wide range of cancers, including non-small cell lung cancer, metastatic melanoma, smoldering multiple myeloma, pediatric hypermutant cancers, pediatric brain tumors and pediatric neuroblastoma. Funding has also supported Convergence Grants, which harness computational science to understand fundamental cancer biology, Innovative Research Grants focused on immuno-oncology, as well as Dream Teams focused on lung cancer.

Stand Up To Cancer’s Health Equity Initiative formalizes requirements that will apply to all future teams seeking Stand Up To Cancer funding. The requirements include addressing recruitment and retention of patients from different ethnic groups and underserved communities to improve diverse participation in cancer clinical trials. To improve cancer clinical trial education, outreach and recruitment in underserved communities, Stand Up To Cancer is collaborating with advocacy and community-based organizations such as the Black Women’s Health Imperative and Friends of Cancer Research.

Bristol Myers Squibb has long been committed to promoting heath equity and continues to forge collaborations and invest in programs to increase the reach of medical innovation to diverse and heavily burdened populations. An important example of the company’s commitment in this area is the work of the Bristol Myers Squibb Foundation, which for more than 20 years has launched initiatives around the world to improve the health outcomes of those disproportionately affected by serious diseases. This includes initiatives focused on underserved populations in the Southeast United States where the lung cancer burden is the highest, with a tailored focus on innovative models of prevention, detection, and education while helping people with lung cancer access and navigate cancer care and support services. From 2014-2019, the Bristol Myers Squibb Foundation committed $35 million to expand the scope of community-based resources and cancer survivorship support programs to underserved populations in the U.S.

About Stand Up To Cancer

Stand Up To Cancer® (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Industry Foundation, a 501(c)(3) charitable organization, was established in 2008 by media and entertainment leaders who utilize these communities’ resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention, and to highlight progress being made in the fight against the disease. As of January 2020, more than 1,600 scientists representing more than 180 institutions are involved in SU2C-funded research projects.

Under the direction of our Scientific Advisory Committee, led by Nobel laureate Phillip A. Sharp, Ph.D., SU2C operates rigorous competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and ensure collaboration across research programs.

Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Sung Poblete, Ph.D., R.N., serves as SU2C’s CEO. For more information, visit StandUpToCancer.org.

About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Logo – https://mma.prnewswire.com/media/592026/SU2C_Logo.jpg
Logo – https://mma.prnewswire.com/media/1215447/Bristol_Myers_Squibb_Logo.jpg

SOURCE Stand Up To Cancer

Unidos Contra El Cáncer® anuncia nueva iniciativa de investigación y educación dedicada a mejorar la igualdad en la salud para los pacientes de pocos recursos que tienen cáncer de pulmón

Acerca de Unidos Contra El Cáncer

Logo – https://mma.prnewswire.com/media/1082531/Unidos_Contra_El_Cancer_Logo.jpg
Logo – https://mma.prnewswire.com/media/1215551/bms_logo_rgb_pos_300_Logo.jpg

FUENTE Unidos Contra El Cáncer

Hispanics’ Consumer Confidence Increases During Second Quarter of 2020 Despite Persistence of COVID-19

BOCA RATON, Florida, July 16, 2020 /PRNewswire-HISPANIC PR WIRE/ — Consumer confidence among Hispanics in the United States edged higher in the second quarter, even as it became clear that the coronavirus pandemic would not be a temporary disruption.

<img id="prnejpg9d4eleft" title="The Business and Economics Polling Initiative (BEPI) at Florida Atlantic University conducts surveys on…

The Hispanic Consumer Sentiment Index increased to 82.8 from 81.3 in the first quarter, according to the Florida Atlantic University Business and Economics Polling Initiative (FAU BEPI) in FAU’s College of Business. The index is higher than the general population’s consumer confidence sentiment in June of 78.1, as published by the University of Michigan.

Hispanics’ consumer confidence weakened at the end of 2019 as concerns grew that the longest economic expansion in history was due to end. But confidence plummeted in the first quarter of 2020 after the first cases of COVID-19 in the U.S. led to a sweeping shutdown of non-essential businesses and millions of job losses.

«Perhaps what has contributed to the second quarter optimism is the reopening of the economy, low interest rates and deep discounting by businesses desperate to increase sales,» said Monica Escaleras, Ph.D., director of FAU BEPI.

In the second quarter of 2020, fewer Hispanics said they are better off financially than a year ago, but 71 percent said they are more optimistic of their future financial situation, compared with 58 percent who felt that way in the first quarter of 2020.

As for the country’s economic outlook, 46 percent of respondents said they expect good business conditions in the upcoming year, up from 34 percent in the first quarter. Also, 60 percent of respondents are confident in the long-run economic outlook, compared to 57 percent in the first quarter. Hispanics who self-identified as Republicans (70 percent) are more optimistic in the long-run economic outlook of the country than Democrats, Independents and non-registered voters.

Despite the better mood overall, fewer Hispanics in the second quarter (42 percent) believe it is a good time to buy a big-ticket item compared to the first quarter (53 percent).

With consumer confidence increasing, fewer Hispanics disapproved of U.S. President Donald Trump’s performance compared to the first quarter. His disapproval rating fell 5 percentage points, to 49 percent from 56 percent.

The poll is based on a sampling of 741 Hispanics, 18 years of age and older, from March 1 to June 30. The margin of error is +/- 3.60 percentage points.

Logo – https://mma.prnewswire.com/media/214770/bepi_at_florida_atlantic_university_logo.jpg

SOURCE Florida Atlantic University Business and Economics Polling Initiative

Ibn Sina Foundation and CVS Health Expand COVID-19 Testing in Houston with New Site

HOUSTON, July 16, 2020 /PRNewswire-HISPANIC PR WIRE/ — The Ibn Sina Foundation today announced it is launching a second COVID-19 testing site, together with CVS Health, at its Ibn Sina North Shepherd Community Clinic location. CVS Pharmacists and CVS Pharmacy colleagues will staff the testing operation. Testing will be provided at no cost to patients.

<img id="prnejpg7e30left" title="CVS Health (PRNewsFoto/CVS…

«The Ibn Sina Foundation has been serving the uninsured community for the nearly two decades, providing preventive and primary medical, dental, diagnostic and specialty care services through seven community clinics across Greater Houston and Port Arthur areas,» said Mr. Nasruddin Rupani, Chairman of the Ibn Sina Foundation. «We are pleased to work with CVS Health, and today we are excited to add an additional location to provide free COVID-19 testing services to meet the needs of our patients and community members.»

Testing at Ibn Sina North Shepherd Community Clinic, located at 5012 North Shepherd Drive in Houston, will be open to the public by appointment beginning Friday, July 17. Patients will need to pre-register in advance by calling 832-426-3760 to schedule a time slot for testing. A personal vehicle is not required for testing and results will be provided on-the-spot. To be eligible for testing, patients will need to meet criteria established by the Centers for Disease Control and Prevention, in addition to age guidelines.

Rapid COVID-19 testing also continues to be available at the Ibn Sina Wilcrest Community Clinic location, which the Ibn Sina Foundation and CVS Health launched last month.

«Following the strong community response to our first testing site in Houston, we’re pleased to be able to expand our testing capabilities, particularly at a time of urgent and increased need in the region,» said Dr. Garth Graham, Vice President, Community Health and Chief Community Health Officer, CVS Health. «Ibn Sina Foundation’s deep commitment to the residents it serves has made them an invaluable partner as we work to bolster local efforts to manage the spread of the virus and help communities stay healthy.»

The CVS Health Foundation, a charitable entity associated with CVS Health, has a longstanding relationship with the National Association of Free & Charitable Clinics, providing more than $9 million over the last six years to help clinics nationwide, like the Ibn Sina Foundation, to increase access to care for underserved populations.

«Unfortunately people in Houston and Harris County are contracting COVID-19 at an alarming rate, especially in communities of color,» said Congresswoman Sheila Jackson Lee (TX-18). «I have repeatedly called for increased access to COVID-19 testing because testing is the key to saving lives! We must encourage Houstonians, Texans, and Americans to get tested and to continue adhering to CDC guidelines on social distancing and wearing masks. This is a crucial time and there is no doubt more COVID-19 testing is needed. That is why I am so proud of the efforts displayed by the Ibn Sina Foundation and CVS health who are committed to providing more opportunities for no-cost COVID-19 testing to Houston! Only together can we see an end to the COVID-19 health crisis globally, in our nation, and in our beloved state of Texas. Remember, the key to saving lives is testing, testing, testing!»

Ibn Sina Foundation was established in 2001 by a group of business and healthcare professionals. The Foundation’s mission is to ensure the health of the community by providing integrated, preventive and primary care in a clinical setting through the dissemination and application of health-related knowledge, thereby enhancing the quality of life of people.

In addition to offering testing together with several community partners across the country, CVS Health is offering drive-thru testing at more than 1,400 CVS Pharmacy locations nationwide. Nearly sixty percent of these CVS Pharmacy test sites serve communities with significant need for support, as measured by the Centers for Disease Control and Prevention (CDC) Social Vulnerability Index.

Media Contact:
Monica Prinzing, (831) 241-8294
PrinzingM@aetna.com

Logo – https://mma.prnewswire.com/media/487051/CVS_HealthLogo.jpg

SOURCE CVS Health

El Milagro Clinic and CVS Health Launch COVID-19 Testing

MCALLEN, Texas, July 16, 2020 /PRNewswire-HISPANIC PR WIRE/ — El Milagro Clinic today announced it has launched rapid COVID-19 testing, together with CVS Health, at its clinic in the Rio Grande Valley. CVS Pharmacists and pharmacy employees will staff the testing operation. Testing will be provided at no cost to patients.

<img id="prnejpg0d49left" title="CVS Health " border="0" alt="CVS Health " align="middle"…

«We are very excited to be teaming up with CVS Health to increase the much-needed COVID-19 testing services in our region.» said Marisol Resendez, Executive Director, El Milagro Clinic. «This collaboration comes at a most appropriate time as we are experiencing an exponentially increasing amount of positive COVID-19 cases. We know that it is the uninsured and underserved in our community that are at a higher risk from getting severely ill from this virus, and this partnership highlights our commitment to providing healthcare services to the most vulnerable. We are grateful for CVS Health’s vision to expand access to testing to those that need it most.»

Testing at the El Milagro Clinic, located at 901 E. Vermont Avenue in McAllen, will be open to the public by appointment beginning Friday, July 17. Patients will need to pre-register in advance by calling 956-213-6400, to schedule a time slot for testing. Testing at the site is conducted inside the clinic; a personal vehicle is not required and results will be provided on-the-spot. To be eligible for testing, patients will need to meet criteria established by the Centers for Disease Control and Prevention, in addition to age guidelines.

«Working with partners like El Milagro Clinic is an important part of our comprehensive strategy to increase access to COVID-19 testing,» said Dr. Garth Graham, Vice President, Community Health and Chief Community Health Officer, CVS Health. «This joint effort allows us to tap into the network of a trusted organization with strong community ties to further expand testing in areas of greatest need.»

The CVS Health Foundation, a charitable entity associated with CVS Health, has a longstanding relationship with the National Association of Free & Charitable Clinics, providing more than $9 million over the last six years to help clinics nationwide, like El Milagro Clinic, to increase access to care for underserved populations.

«Accessible, abundant, efficient and accurate testing is critical to reining in the surge of COVID-19 in South Texas,» said Congressman Vicente Gonzalez (TX-15). «CVS Health will be an enormous resource and expand access to testing for our vulnerable populations. I am grateful for CVS Health for stepping up and answering our community’s call for help.»

El Milagro Clinic has provided comprehensive primary, disease prevention and behavioral health care services to Rio Grande Valley residents who are medically indigent since 1996.

«Hidalgo County has been identified as one of the nation’s hotspots for COVID-19 with more than 7,000 known positive cases. Testing is essential to contain the spread of the virus,» said Roberto M. Garcia, El Milagro Clinic Board Chair. «Mass testing is taking place at several locations throughout the county; however, these efforts are presently overwhelmed. We welcome the opportunity to partner with CVS Health for COVID-19 testing in the battle against the spread of this virus in our community.»

Media Contact:
Monica Prinzing, (831) 241-8294
PrinzingM@aetna.com

Logo – https://mma.prnewswire.com/media/487051/CVS_HealthLogo.jpg

SOURCE CVS Health

El Milagro Clinic and CVS Health Launch COVID-19 Testing

<img id="prnejpg0d49left" title="CVS Health " border="0" alt="CVS Health " align="middle"…

The CVS Health Foundation, a charitable entity associated with CVS Health, has a longstanding relationship with the National Association of Free & Charitable Clinics, providing more than $9 million over the last six years to help clinics nationwide, like El Milagro Clinic, to increase access to care for underserved populations.

El Milagro Clinic has provided comprehensive primary, disease prevention and behavioral health care services to Rio Grande Valley residents who are medically indigent since 1996.

Media Contact:
Monica Prinzing, (831) 241-8294
PrinzingM@aetna.com

Logo – https://mma.prnewswire.com/media/487051/CVS_HealthLogo.jpg

SOURCE CVS Health

Hispanics’ Consumer Confidence Increases During Second Quarter of 2020 Despite Persistence of COVID-19

<img id="prnejpg9d4eleft" title="The Business and Economics Polling Initiative (BEPI) at Florida Atlantic University conducts surveys on…

Despite the better mood overall, fewer Hispanics in the second quarter (42 percent) believe it is a good time to buy a big-ticket item compared to the first quarter (53 percent).

The poll is based on a sampling of 741 Hispanics, 18 years of age and older, from March 1 to June 30. The margin of error is +/- 3.60 percentage points.

Logo – https://mma.prnewswire.com/media/214770/bepi_at_florida_atlantic_university_logo.jpg

SOURCE Florida Atlantic University Business and Economics Polling Initiative

Ibn Sina Foundation and CVS Health Expand COVID-19 Testing in Houston with New Site

<img id="prnejpg7e30left" title="CVS Health (PRNewsFoto/CVS…

Rapid COVID-19 testing also continues to be available at the Ibn Sina Wilcrest Community Clinic location, which the Ibn Sina Foundation and CVS Health launched last month.

Media Contact:
Monica Prinzing, (831) 241-8294
PrinzingM@aetna.com

Logo – https://mma.prnewswire.com/media/487051/CVS_HealthLogo.jpg

SOURCE CVS Health

La Confianza del Consumidor entre los Hispanos Aumenta Durante el Segundo Trimestre del 2020 No Obstante la Persistencia del COVID-19

BOCA RATON, Florida, 16 de julio de 2020 /PRNewswire-HISPANIC PR WIRE/ — La confianza del consumidor entre los hispanos de los EEUU aumentó en el segundo trimestre, aún cuando era evidente que la pandemia del coronavirus no sería un contratiempo temporario.

<img id="prnejpg3635left" title="The Business and Economics Polling Initiative (BEPI) at Florida Atlantic University conducts surveys on business, economic, political, and social issues…

El Indice de Sentimiento del Consumidor Hispano aumentó de 81,3 a 82,8 durante el primer trimestre, conforme a la Iniciativa de la Encuesta sobre Economía y Negocios de la Universidad Florida Atlantic(FAU BEPI) en la Escuela de Negocios de FAU. El índice es más alto que el índice de sentimiento del consumidor para la población global, que en junio era del 78,1, según lo publicado por la Universidad de Michigan.

La confianza del consumidor hispano se debilitó a fines del 2019 dado que existía una creciente preocupación de que la expansión más larga de la economía en la historia estaba destinada a sucumbir. Pero la confianza se derrumbó en el primer trimestre del 2020 después que los primeros casos del COVID-19 en los EE UU causaron un cierre arrasador de negocios de caracter no esencial y una pérdida de millones de empleos.

«Tal vez lo que ha contribuído al optimismo del segundo trimestre es la reapertura de la economía, las bajas tasas de interés y los considerables descuentos por parte de los negocios muy ansiosos por incrementar las ventas» – manifestó Mónica Escaleras, Ph.D., directora de FAU BEPI.

En el segundo trimestre del 2020, un número menor de hispanos manifestaron estar mejor económicamente que el año anterior, pero un 71 por ciento de ellos indicaron que se encuentran más optimistas acerca de su futura situación económica, lo cual muestra un incremento respecto del primer trimestre del 2020 cuando un 58 por ciento de los mismos se manifestaban al respecto.

Con respecto a la perspectiva económica del país, el 46 por ciento de los que respondieron la encuesta manifestaron que esperan buenas condiciones económicas para el año entrante, comparado con el porcentaje del 34 por ciento del primer trimestre. Además, el 60 por ciento de los que respondieron la encuesta tienen confianza en la perspectiva económica a largo plazo, en contraste con el porcentaje del 57 por ciento en el primer trimestre. Los hispanos que se autoidentificaron como Republicanos (el 70 por ciento) son más optimistas en la perspectiva económica del país a largo plazo que los Demócratas, los Independientes y los votantes no registrados.

A pesar del mejor estado anímico general, un número menor de hispanos en el segundo trimestre (un 42 por ciento) creen que éste es un buen momento para comprar artículos para el hogar de alto valor económico, comparado con el porcentaje del primer trimestre (un 53 por ciento).

Al incrementarse la confianza del consumidor, un número menor de hispanos están en desacuerdo con el desempeño del Presidente de EE UU Donald Trump, comparado con el primer trimestre. Este porcentaje de desaprobación cayó 5 puntos, del 56 por ciento al 49 por ciento.

La muestra consistió en 741 hispanos de 18 años o mayores de 18, y se llevó a cabo desde el 1ro de marzo hasta el 30 de junio. El margen de error es de +/-3,60 por ciento.

Logo – http://photos.prnewswire.com/prnh/20150508/214770LOGO

FUENTE Florida Atlantic University Business and Economics Polling Initiative